Modeling and simulation of the exposure–response and dropout pattern of guanfacine extended-release in pediatric patients with ADHD-Reference-Cited by-同舟云学术

Modeling and simulation of the exposure–response and dropout pattern of guanfacine extended-release in pediatric patients with ADHD

Published:2014-11-06 Issue:1 Volume:42 Page:45-65
ISSN:1567-567X
Container-title:Journal of Pharmacokinetics and Pharmacodynamics
language:en
Short-container-title:J Pharmacokinet Pharmacodyn

Author:

Knebel William,Rogers Jim,Polhamus Dan,Ermer James,Gastonguay Marc R.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s10928-014-9397-6.pdf

Reference27 articles.

1. National Institute of Mental Health (2008) Attention Deficit Hyperactivity Disorder (ADHD), 08-3572 edn. US Department of Health and Human Services

2. Biederman J, Faraone SV (2005) Attention-deficit hyperactivity disorder. Lancet 366:237–248

3. Wolraich M, Brown L, Brown RT, et al (2011) Implementing the key action statements: an algorithm and explanation for process of care for the evaluation, diagnosis, treatment, and monitoring of ADHD in children and adolescents. Pediatrics 128:SI1–SI21

4. INTUNIV® (guanfacine) extended-release tablets [package insert]

5. Roberts MS, Nucifora KA, Braithwaite RS (2010) Using mechanistic models to simulate comparative effectiveness trials of therapy and to estimate long-term outcomes in HIV care. Med Care 48:S90–S95

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging Role of Organ‐on‐a‐Chip Technologies in Quantitative Clinical Pharmacology Evaluation;Clinical and Translational Science;2019-03

2. Quantitative Pharmacology Assessment Strategy Therapeutic Proteins in Pediatric Subjects - Challenges and Opportunities;Quantitative Pharmacology and Individualized Therapy Strategies in Development of Therapeutic Proteins for Immune-Mediated Inflammatory Diseases;2019-02-15

3. Pharmacokinetic–Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of Clearance;Clinical Pharmacokinetics;2018-04-19

4. Role of Quantitative Clinical Pharmacology in Pediatric Approval and Labeling;Drug Metabolism and Disposition;2016-04-14

5. Pediatric Clinical Trial Design and Dosing;Fundamentals of Pediatric Drug Dosing;2016